Skip to content
Advertisement

FILE - In this Feb. 23, 2021, file photo, health workers look at a vial and a syringe while administering a dose of the Sinovac Biotech COVID-19 vaccine at a community vaccination center in Hong Kong. Hong Kong's sudden suspension of a COVID-19 vaccine developed by Pfizer and BioNTech is another blow to a vaccination program already struggling against a wall of public distrust. Hong Kong on Wednesday, March 24, 2021, suspended use of the Pfizer vaccine, distributed by Chinese pharmaceutical firm Fosun Pharma, after defective packaging such as loose vial lids and cracks on bottles were found in one of two batches of the vaccine. (Paul Yeung/Pool Photo via AP, File)

FILE - In this Feb. 23, 2021, file photo, health workers look at a vial and a syringe while administering a dose of the Sinovac Biotech COVID-19 vaccine at a community vaccination center in Hong Kong. Hong Kong's sudden suspension of a COVID-19 vaccine developed by Pfizer and BioNTech is another blow to a vaccination program already struggling against a wall of public distrust. Hong Kong on Wednesday, March 24, 2021, suspended use of the Pfizer vaccine, distributed by Chinese pharmaceutical firm Fosun Pharma, after defective packaging such as loose vial lids and cracks on bottles were found in one of two batches of the vaccine. (Paul Yeung/Pool Photo via AP, File)

Featured Photo Galleries